Asundexian (Bayer) significantly reduces the risk of ischemic stroke compared with placebo, without increasing the risk of ...

Cardiology can learn lessons from geriatric medicine on how to look at the big picture and involve patients in the process.

Reinvigorating bedside clinical medicine, long-term melatonin risks, low telenursing adoption rates, and more.

Kenneth Rosenfield explores the barriers and the solutions to lack of access in the management of pulmonary embolism.

Stenting, but not endarterectomy, significantly reduced stroke risk compared with intensive medical therapy alone.

Extra scrutiny is warranted to identify the underlying causes of chest pain in patients with nonobstructive coronary disease ...

High systolic blood pressure in adolescence is tied to a significantly higher risk of developing coronary atherosclerosis ...

Ami Bhatt, Jenny Zablah, and Gareth Morgan discuss new advanced imaging approaches for treating congenital heart disease.

The PFA-SHAM trial and MANIFEST-US registry support the efficacy and safety of the increasingly used ablation modality.

The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.

Quantifying blood flow instead of relying on angiography alone led to a change in diagnosis for 53% of patients.

Some question if patients want this information, but others say this tool can put risk into context and prompt lifestyle ...